Efficacy and safety of a personalized vitamin D3 loading dose followed by daily 2000 IU in colorectal cancer patients with vitamin D insufficiency: interim analysis of a randomized controlled trial
A personalized vitamin D3 loading dose has not yet been tested in cancer patients. This interim analysis of the randomized, placebo-controlled VICTORIA trial analyzed the first recruited 74 German adults with nonmetastatic colorectal cancer, a tumor surgery within the past year, and 25-hydroxyvitami...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Langue: | anglais |
| Publié: |
28 October 2022
|
| In: |
Nutrients
Year: 2022, Volume: 14, Numéro: 21, Pages: 1-15 |
| ISSN: | 2072-6643 |
| DOI: | 10.3390/nu14214546 |
| Accès en ligne: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3390/nu14214546 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6643/14/21/4546 
|
| Notes sur l'auteur: | Sabine Kuznia, David Czock, Annette Kopp-Schneider, Reiner Caspari, Harald Fischer, Dana Clarissa Laetsch, Marija Slavic, Hermann Brenner and Ben Schöttker |
| Résumé: | A personalized vitamin D3 loading dose has not yet been tested in cancer patients. This interim analysis of the randomized, placebo-controlled VICTORIA trial analyzed the first recruited 74 German adults with nonmetastatic colorectal cancer, a tumor surgery within the past year, and 25-hydroxyvitamin D levels (25(OH)D) < 50 nmol/L. |
|---|---|
| Description: | Gesehen am 31.01.2023 |
| Description matérielle: | Online Resource |
| ISSN: | 2072-6643 |
| DOI: | 10.3390/nu14214546 |